A Clinical Trial of Decitabine in Relapse and Refractory Diffuse Large B Cell Lymphoma

Clinical trial NCT03579082 · UNKNOWN

Trial details

NCT number: NCT03579082
Sponsor: Mingzhi Zhang
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Diffuse Large B Cell Lymphoma

Start date: 2018-06-01
Primary completion: 2019-06-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.